Hospital
Baptist Medical Center of Nassau INC
Baptist Medical Center of Nassau INC was paid $3.46M by Medicaid between Jan 2018 and Nov 2024, across 77 billing codes. Its largest line is 99283, emergency room visit (moderate) — 19% of everything it billed.
33Billing provider infoBAPTIST MEDICAL CENTER OF NASSAU INC
FERNANDINA BEACH, FL 32034
FERNANDINA BEACH, FL 32034
33aNPI1518024462assigned 01/02/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.46M
24GClaims69,115
24DCodes billed77
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#98 of 163
Median peer was paid$4.77M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,166 | $161K | |
| 2019 | 15,142 | $590K | |
| 2020 | 13,234 | $572K | |
| 2021 | 14,206 | $805K | |
| 2022 | 16,264 | $1.05M | |
| 2023 | 2,977 | $264K | |
| 2024incomplete | 126 | $14K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 6,181 | 5,347 | $660K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 4,505 | 3,756 | $634K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 16% | 2,974 | 2,399 | $540K |
| 96361 | Intravenous infusion, hydration; each additional hour | 12% | 1,671 | 1,386 | $400K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.8% | 2,249 | 1,956 | $202K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.6% | 4,028 | 3,079 | $123K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.1% | 2,330 | 1,855 | $71K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2.0% | 332 | 277 | $70K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.0% | 437 | 358 | $68K |
| 81025 | 1.7% | 2,296 | 1,931 | $58K | |
| 80053 | Comprehensive metabolic panel | 1.6% | 2,644 | 2,058 | $55K |
| 99205 | Prolong outpt/office vis | 1.3% | 564 | 323 | $46K |
65 more codes
| 70450 | Computed tomography, head or brain; without contrast material | 1.3% | 739 | $44K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 6,346 | $36K |
| 81001 | <1% | 3,647 | $34K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 427 | $30K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 552 | $26K |
| 87631 | <1% | 248 | $26K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 929 | $21K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,827 | $20K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,585 | $20K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 217 | $20K |
| 59025 | Fetal non-stress test | <1% | 285 | $18K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 115 | $18K |
| 80305 | <1% | 560 | $17K | |
| 84484 | <1% | 2,219 | $16K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,727 | $16K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 267 | $15K |
| 80076 | <1% | 1,434 | $12K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,278 | $12K |
| 83690 | <1% | 1,408 | $12K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,312 | $12K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 439 | $11K |
| 87088 | <1% | 1,449 | $11K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 501 | $10K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 929 | $10K |
| 81003 | <1% | 667 | $9K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 22 | $7K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 766 | $5K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 64 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 383 | $4K |
| 87430 | <1% | 373 | $4K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 120 | $3K |
| 85610 | <1% | 861 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 846 | $3K |
| 82962 | <1% | 150 | $3K | |
| 80061 | Lipid panel | <1% | 56 | $2K |
| 82150 | <1% | 311 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 221 | $2K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 40 | $1K |
| 83880 | <1% | 125 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 13 | $1K |
| J2704 | Injection, propofol, 10 mg | <1% | 28 | $1K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 15 | $956.67 |
| 82565 | <1% | 94 | $795.84 | |
| 80051 | <1% | 87 | $715.55 | |
| 84520 | <1% | 87 | $715.55 | |
| 82310 | <1% | 86 | $715.55 | |
| 82947 | <1% | 87 | $715.55 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 93 | $709.52 |
| 85730 | <1% | 292 | $461.45 | |
| 87077 | <1% | 31 | $303.10 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 77 | $295.12 |
| 87081 | <1% | 47 | $285.04 | |
| 85027 | <1% | 50 | $221.00 | |
| 85007 | <1% | 29 | $190.27 | |
| 87186 | <1% | 63 | $173.48 | |
| 82550 | <1% | 63 | $147.74 | |
| 82553 | <1% | 42 | $146.27 | |
| 85652 | <1% | 14 | $97.40 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 17 | $81.35 |
| 83735 | <1% | 35 | $55.15 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 14 | $42.04 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 43 | $0.00 |
| 86901 | 0% | 19 | $0.00 | |
| 84704 | 0% | 19 | $0.00 | |
| 84702 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOYCE, PHILIP (CHIEF REVENUE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Southern Baptist Hospital of Florida INC | Jacksonville, FL | $87.92M |
| Southern Baptist Hospital of Florida, INC | Jacksonville, FL | $3.49M |
| Southern Baptist Hospital of Florida, INC | Jacksonville, FL | $3.32M |
| Baptist Medical Center of the Beaches, INC | Jacksonville Beach, FL | $3.21M |
| Southern Baptist Hospital of Florida, INC | Fleming Island, FL | $1.70M |
| Southern Baptist Hospital of Florida, INC | Jacksonville, FL | $1.30M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.